<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02706275</url>
  </required_header>
  <id_info>
    <org_study_id>201512121</org_study_id>
    <nct_id>NCT02706275</nct_id>
  </id_info>
  <brief_title>Pilot Trial of External Warming in Septic Patients</brief_title>
  <official_title>Pilot Randomized Trial of External Warming in Critically Ill Adult Septic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether externally warming critically ill afebrile
      adult septic patients will improve indices of immune function and/or clinical outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Monocyte human leukocyte antigen (mHLA-DR) expression</measure>
    <time_frame>48 hours hours following the start of the intervention period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interferon (IFN)-gamma production</measure>
    <time_frame>48 hours following the start of the intervention period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients who acquire nosocomial infections</measure>
    <time_frame>30 days after diagnosis of sepsis</time_frame>
    <description>Number of patients who develop a nosocomial infection (defined as a new infection diagnosed greater than 48 hours after the original sepsis diagnosis) within 30 days of the sepsis diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients in whom the intervention is stopped early secondary to hemodynamic changes related to the intervention</measure>
    <time_frame>Through study completion, 2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">56</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Warming Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>External warming via forced air warming</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care body temperature management</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>External warming</intervention_name>
    <description>External warming via forced air warming to a goal body temperature 1.5°C greater than the baseline minimum temperature (within previous 24 hours) for 48 hours</description>
    <arm_group_label>Warming Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to a surgical or medical intensive care unit

          -  Age greater than 18 years

          -  Diagnosis of sepsis within 24 hours of enrollment

          -  Requirement for mechanical ventilation with expected duration of mechanical
             ventilation &gt; 48 hours

          -  Goal Richmond Agitation Sedation Scale (RASS) &lt; 0

          -  Maximum baseline temperature (within previous 24 hours) &lt; 38.3°C

        Exclusion Criteria:

          -  Treatment with chemotherapy within 6 months of enrollment

          -  Treatment with corticosteroids at a dose &gt; 300 mg/day hydrocortisone (or equivalent)

          -  History of solid organ transplant on any immunosuppression medication

          -  History of immunological disease

          -  History of chronic infection with hepatitis B or C virus

          -  History of acute stroke, acute coronary syndrome, or severe head injury requiring
             osmotic therapy within 7 days prior to enrollment

          -  History of multiple sclerosis

          -  Contraindications to both bladder or esophageal core temperature monitors or to forced
             air warming blankets

          -  Moribund status

          -  Sepsis without source control
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne M Drewry, MD</last_name>
    <email>drewrya@anest.wustl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne M Drewry, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2016</study_first_submitted>
  <study_first_submitted_qc>March 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2016</study_first_posted>
  <last_update_submitted>November 1, 2017</last_update_submitted>
  <last_update_submitted_qc>November 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

